|
|
||||||||
The Journal of Immunology, Vol 137, Issue 8 2514-2521, Copyright © 1986 by American Association of Immunologists
ARTICLES |
GM Shearer, DC Bernstein, KS Tung, CS Via, R Redfield, SZ Salahuddin and RC Gallo
Functional analyses of peripheral blood leukocytes (PBL) from high risk HTLV-III antibody-negative and antibody-positive donors, as well as from patients with acquired immune deficiency syndrome (AIDS), lymphadenopathy syndrome (LAS), and AIDS-related complex (ARC) were performed by the in vitro generation of cytotoxic T lymphocyte (CTL) and proliferative responses to the HLA self-restricted antigens of influenza virus (S + X) and to nonself restricted HLA alloantigens (ALLO). All 40 antibody-negative donors tested responded to both S + X and ALLO in the CTL response, whereas six of 14 antibody-positive, two of three LAS, four of five ARC, and seven of 17 AIDS patients exhibited a selective absence of CTL to S + X, but generated normal or elevated CTL responses to ALLO. Of the remaining 10 AIDS patients, nine did not respond to either S + X or ALLO, and one responded to both S + X and ALLO. A similar selective loss of the proliferative response to S + X was found. We also observed antibody-positive donors who initially generated CTL responses to S + X and ALLO, but lost the S + X response as a function of time. We were able to restore the selective loss of S + X CTL activity in vitro by the addition of IL 2 and, to some extent, by co-stimulation with S + X plus ALLO. Depletion of CD4+ T helper cells and removal of autologous antigen-presenting cells from the PBL of healthy antibody-negative donors indicated that distinct T helper cell subsets exist in human PBL, and that S + X responses must use a CD4+ T helper population, whereas ALLO responses can utilize an alternate CD4- T helper pathway. A model is presented indicating the selective depletion of CD4+ T helper function in the developmental stages of AIDS. The functional test for T helper activity to self restricted antigens may be the earliest indicator of immune functional loss in the development of AIDS, and may precede a reduction in the absolute number of CD4+ cells.
This article has been cited by other articles:
![]() |
H. Guan, M. Moretto, D. J. Bzik, J. Gigley, and I. A. Khan NK Cells Enhance Dendritic Cell Response against Parasite Antigens via NKG2D Pathway J. Immunol., July 1, 2007; 179(1): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beck The Immunocompromised Host: HIV Infection Proceedings of the ATS, December 1, 2005; 2(5): 423 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Combe, T. J. Curiel, M. M. Moretto, and I. A. Khan NK Cells Help To Induce CD8+-T-Cell Immunity against Toxoplasma gondii in the Absence of CD4+ T Cells Infect. Immun., August 1, 2005; 73(8): 4913 - 4921. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moretto, L. Casciotti, B. Durell, and I. A. Khan Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection Infect. Immun., November 1, 2000; 68(11): 6223 - 6232. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Messele, M. T. L. Roos, D. Hamann, M. Koot, A. L. Fontanet, F. Miedema, P. T. A. Schellekens, and T. F. Rinke de Wit Nonradioactive Techniques for Measurement of In Vitro T-Cell Proliferation: Alternatives to the [3H]Thymidine Incorporation Assay Clin. Vaccine Immunol., July 1, 2000; 7(4): 687 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cicala, J. Arthos, A. Rubbert, S. Selig, K. Wildt, O. J. Cohen, and A. S. Fauci HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells PNAS, February 1, 2000; 97(3): 1178 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Khan, W. R. Green, L. H. Kasper, K. A. Green, and J. D. Schwartzman Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host Infect. Immun., November 1, 1999; 67(11): 5869 - 5876. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Urnovitz, J. C. Sturge, T. D. Gottfried, and W. H. Murphy Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection Clin. Chem., September 1, 1999; 45(9): 1602 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Segura, C. Delmelle-Wibaut, M. Janssens, Y. Cleuter, A. van den Broeke, R. Kettmann, and K. E. Willard-Gallo Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-gamma Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1 J. Virol., June 1, 1999; 73(6): 5207 - 5213. [Abstract] [Full Text] |
||||
![]() |
N. Selliah and T. H. Finkel Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness J. Immunol., June 15, 1998; 160(12): 5697 - 5701. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Trimble and J. Lieberman Circulating CD8 T Lymphocytes in Human Immunodeficiency Virus-Infected Individuals Have Impaired Function and Downmodulate CD3zeta , the Signaling Chain of the T-Cell Receptor Complex Blood, January 15, 1998; 91(2): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Herbein, C. Van Lint, J. L. Lovett, and E. Verdin Distinct Mechanisms Trigger Apoptosis in Human Immunodeficiency Virus Type 1-Infected and in Uninfected Bystander T Lymphocytes J. Virol., January 1, 1998; 72(1): 660 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. X. Wu and S. F. Schlossman Decreased ability of HIV-1 Tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells PNAS, December 9, 1997; 94(25): 13832 - 13837. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Phipps, S. Yousefi, and D. R. Branch Increased Enzymatic Activity of the T-Cell Antigen Receptor-Associated Fyn Protein Tyrosine Kinase in Asymptomatic Patients Infected With the Human Immunodeficiency Virus Blood, November 1, 1997; 90(9): 3603 - 3612. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Meyaard, E. Hovenkamp, N. Pakker, T. C.T.M. van der Pouw Kraan, and F. Miedema Interleukin-12 (IL-12) Production in Whole Blood Cultures From Human Immunodeficiency Virus-Infected Individuals Studied in Relation to IL-10 and Prostaglandin E2 Production Blood, January 15, 1997; 89(2): 570 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Viscidi, K Mayur, H. Lederman, and A. Frankel Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1 Science, December 22, 1989; 246(4937): 1606 - 1608. [Abstract] [PDF] |
||||
![]() |
A. Fauci The human immunodeficiency virus: infectivity and mechanisms of pathogenesis Science, February 5, 1988; 239(4840): 617 - 622. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |